NCT04522687
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +15 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Clinical trial condition
Esophageal Squamous Cell Carcinoma
Explore clinical trials studying Esophageal Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.
213 public trials
81 recruiting studies
Esophageal Squamous Cell Carcinoma trial results
Not yet recruiting
PhII Study of Toripalimab Followed by Definitive CRT & Adjuvant Toripalimab in Locally Advanced ESCC
NCT07836049
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Vanderbilt University Medical Center Nashville, Tennessee, United States
Not yet recruiting
Immunotherapy Plus Anlotinib After Surgery for Esophageal Squamous Cell Cancer With Residual Tumor and Positive Lymph Nodes
NCT07830355
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
Not specified
Not yet recruiting
Neoadjuvant Sacituzumab Tirumotecan Plus Toripalimab in Locally Advanced Esophageal Squamous Cell Carcinoma
NCT07823270
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Hebei Medical University Fourth Hospital Shijiazhuang, Hebei, China
Not yet recruiting
Paclitaxel Polymeric Micelles and Cisplatin Plus Sintilimab as Neoadjuvant Therapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
NCT07799077
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- The Fourth Hospital of Hebei Medical University Hebei, Shijiazhuang, China
NCT07769658
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
- Henan Provincial Chest Hospital (Zhengzhou University Affiliated Chest Hospital) Zhengzhou, Henan, China
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Not yet recruiting
Becotatug Vedotin Plus Tislelizumab and Low-Dose Lenvatinib for Advanced Esophageal Squamous Cell Carcinoma, Phase II
NCT07686926
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
Not specified
Not yet recruiting
Becotatug Vedotin Plus Cisplatin and Radiotherapy in LA-ESCC
NCT07697040
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- The Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China
Not yet recruiting
Precision Medicine for Immunotherapy-Resistant Advanced Esophageal Cancer
NCT07653451
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
Not specified
Not yet recruiting
A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
NCT07623642
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +55 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China